DrugPatentWatch Database Preview
Encube Company Profile
» See Plans and Pricing
What is the competitive landscape for ENCUBE, and what generic and branded alternatives to ENCUBE drugs are available?
ENCUBE has ten approved drugs.
Drugs and US Patents for Encube
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Encube Ethicals | PERMETHRIN | permethrin | CREAM;TOPICAL | 211303-001 | Apr 3, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
Encube Ethicals | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | SOLUTION;TOPICAL | 209913-001 | Feb 13, 2019 | AT | RX | No | No | Start Trial | Start Trial | ||||
Encube | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211297-001 | Oct 13, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.